AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9308977
Drug: High-dose pyridoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose pyridoxine (30 or 50 mg/kg/day) by intravenous infusion
Trial: 3548301
Drug: Sustained-release diltiazem,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release diltiazem, 120 to 180 mg twice daily
Trial: 3548301
Drug: Hydrochlorothiazide, 25
RxNorm normalized name: HydroCHLOROthiazide, 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide, 25 to 50 mg twice daily
Trial: 3548301
Drug: Hydrochlorothiazide, 50
RxNorm normalized name: HydroCHLOROthiazide, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide, 50 mg/day
Trial: 30342255
Drug: Newsletter program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newsletter program (monthly mailings and family-focused healthy lifestyle information)
Trial: 26464170
Drug: Best available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Best available drug treatment (group B; N=261 patients)
Trial: 22197071
Drug: C1-inhibitor concentrate
RxNorm normalized name: C1 INHIBITOR
DrugBank: Conestat alfa (DB09228)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: C1-inhibitor concentrate (C1-INH)
Trial: 22197071
Drug: C1-inhibitor concentrate
RxNorm normalized name: C1 INHIBITOR
DrugBank: Conestat alfa (DB09228)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: C1-inhibitor concentrate (C1-INH-NF)
Trial: 21153932
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (listening to music through headphones for one hour after surgery)
Trial: 18764771
Drug: ETR (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETR (400 mg or 800 mg twice daily)
Trial: 18764771
Drug: ETR (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETR (800 mg or 1200 mg twice daily)
Trial: 16269047
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with triple-therapy (azathioprine, methylprednisolone, cyclosporine)
Trial: 7011354
Drug: Combined infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined infusion of aminophylline and salbutamol
Trial: 19452376
Drug: Rivastigmine 6
RxNorm normalized name: rivastigmine 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivastigmine 6 mg/day
Trial: 14521803
Drug: Platinum/paclitaxel-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum/paclitaxel-based chemotherapy
Trial: 8686816
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous propofol anaesthesia (median total dose of propofol 710 mg)
Trial: 8686816
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous propofol anaesthesia
Trial: 1839799
Drug: Concomitant antibiotic‐anti‐inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant antibiotic‐anti‐inflammatory therapy
Trial: 6633131
Drug: Carbon dioxide
RxNorm normalized name: Carbon Dioxide
DrugBank: Carbon dioxide (DB09157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon dioxide laser treatment
Trial: 25007361
Drug: ABT 50
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT 50 mg
Trial: 22687392
Drug: modafinil 200
RxNorm normalized name: modafinil 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modafinil 200 mg daily
Trial: 19735903
Drug: Opioid rotation
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid rotation using equianalgesic dose tables
Trial: 19735903
Drug: Starting dose
RxNorm normalized name: Austedo 6 MG Starting Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Starting dose of new opioid based on relative potency
Trial: 17623486
Drug: Milk supplemented
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk supplemented with 3 g CLA (cis-9, trans-11 and trans-10, cis-12)
Trial: 15886218
Drug: Octreotide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (300 microg b.i.d.) added to diuretics (furosemide and spironolactone)
Trial: 15886218
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of diuretics
Trial: 15886218
Drug: Diuretics (furosemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics (furosemide and spironolactone)
Trial: 8587482
Drug: Albuterol (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (16 mg.d‐1)
Trial: 8587482
Drug: Albuterol with
RxNorm normalized name: albuterol with CFC 90 mcg/inh inhalation aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol with resistance exercise
Trial: 2676872
Drug: Bunazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bunazosin (1 to 3 mg t.i.d.)
Trial: 2676872
Drug: Propranolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (10 to 40 mg t.i.d.)
Trial: 367426
Drug: extra‐amniotic prostaglandin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: extra‐amniotic prostaglandin E2 gel
Trial: 367426
Drug: oral prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral prostaglandin E2
Trial: 28550827
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (pantoprazol, amoxicillin, and clarithromycin 12/12 hours for 14 days)
Trial: 28550827
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (pantoprazol 12/12 hours for 10 days, amoxicillin 12/12 hours for days 1-5, and clarithromycin plus metronidazol 12/12 hours during days 6-10)
Trial: 26111333
Drug: Postoperative antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative antibiotics (oral amoxicillin 50 mg/kg/day for 5 days)
Trial: 23221573
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (FXCO) - 20.6 g ALA/d
Trial: 23221573
Drug: High-oleic acid
RxNorm normalized name: Oleic Acid
DrugBank: Oleic Acid (DB04224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-oleic acid canola oil (HOCO) - 2.4 g ALA/d
Trial: 23221573
Drug: Western diet
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western diet (WD) - 1.3 g ALA/d
Trial: 19796303
Drug: 25% H(2)O(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% H(2)O(2) gel with light enhancement
Trial: 19796303
Drug: 25% H(2)O(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% H(2)O(2) gel alone
Trial: 14703424
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg tramadol
Trial: 14703424
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg tramadol plus 0.1 mg droperidol
Trial: 1290441
Drug: Paracervical block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracervical block using 20 ml of 1% lignocaine
Trial: 1290441
Drug: Uterosacral block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uterosacral block using 2 ml of 2% lignocaine
Trial: 27028981
Drug: Betahistine (48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betahistine (48 mg/d)
Trial: 22235353
Drug: Albendazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (400 mg) in co-infected children with O. viverrini
Trial: 22235353
Drug: Mebendazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole (500 mg) in co-infected children with O. viverrini
Trial: 19515110
Drug: PPI (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI (lansoprazole 15 mg/d)
Trial: 19765430
Drug: Control (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (conventional therapies)
Trial: 16078671
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sertraline daily for 12 weeks
Trial: 16078671
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sertraline daily plus 50 mg sildenafil as needed for 12 weeks
Trial: 11953346
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor omeprazole
Trial: 24720340
Drug: Nurotron Venus
RxNorm normalized name: Zeltnera venusta whole flowering extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurotron Venus cochlear implants
Trial: 16652049
Drug: Interruption of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interruption of antiretroviral medication
Trial: 16652049
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of antiretroviral therapy
Trial: 8641639
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous immunoglobulins (IVIG) 300 mg/kg every 4 weeks for 6 months
Trial: 8641639
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous immunoglobulins (IVIG)
Trial: 23228814
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (PCV)
Trial: 18290777
Drug: All-trans retinoic
RxNorm normalized name: all trans Retinoic acid
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-trans retinoic acid (ATRA) monotherapy for 12 weeks
Trial: 18290777
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ATRA and PegIFN‐alpha2a for 12 weeks
Trial: 14614633
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (15 mg/kg/day) alone
Trial: 14614633
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (15 mg/kg/day) plus low-dose aspirin (100 mg/day)
Trial: 8368986
Drug: Benadryl (diphenhydramine)
RxNorm normalized name: diphenhydramine Oral Solution [Benadryl]
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benadryl (diphenhydramine) 50 mg
Trial: 8368986
Drug: Hismanal (astemizole)
RxNorm normalized name: Astemizole
DrugBank: Astemizole (DB00637)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hismanal (astemizole) 10 mg
Trial: 30241517
Drug: 3 days
RxNorm normalized name: Transderm Scop 1mg/3 days Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 days of amoxicillin dispersible tablets (DT) followed by 2 days of placebo DT
Trial: 30241517
Drug: 5 days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 days of amoxicillin dispersible tablets (DT)
Trial: 26603771
Drug: Methylprednisolone injection
RxNorm normalized name: methylprednisolone Injection
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone injection
Trial: 24202666
Drug: wDP (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: wDP (docetaxel 35 mg/m² + cisplatin 60 mg/m²)
Trial: 24202666
Drug: wDO (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: wDO (docetaxel 35 mg/m² + oxaliplatin 120 mg/m²)
Trial: 23710844
Drug: email health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: email health information prescriptions (eHIP)
Trial: 23710844
Drug: paper health
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: paper health information prescriptions (pHIP)
Trial: 18500605
Drug: Epidural ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ropivacaine plus IV acetaminophen
Trial: 15820798
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (minimal stimulation protocol)
Trial: 10527011
Drug: No ICD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ICD therapy (Control)
Trial: 28049736
Drug: Liraglutide (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (4 months treatment)
Trial: 25856169
Drug: High-dose caffeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose caffeine (80 mg/kg i.v.)
Trial: 25856169
Drug: Standard-dose caffeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose caffeine (20 mg/kg i.v.)
Trial: 23120958
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education at Kenyatta National Hospital (KNH)
Trial: 18948162
Drug: quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: quetiapine XR 300 mg once daily
Trial: 18948162
Drug: quetiapine IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: quetiapine IR 150 mg twice daily
Trial: 18948162
Drug: quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: quetiapine XR 300 mg once daily and quetiapine IR 150 mg twice daily
Trial: 17990061
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (1 mg or 2 mg)
Trial: 17990061
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (1 mg or 2 mg) with motion stimulation
Trial: 14512795
Drug: Paclitaxel monotherapy
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel monotherapy (100 mg/m2 intravenously on day 1 each week for 6 weeks)
Trial: 14512795
Drug: Paclitaxel and
RxNorm normalized name: paclitaxel and encequidar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel and carboplatin combination (Paclitaxel 80 mg/m2 intravenously followed by carboplatin 200 mg/m2 on day 1 each week for 6 weeks)
Trial: 2249011
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiotherapy (C + R group)
Trial: 27271517
Drug: Psychotherapeutic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapeutic treatment recommendation implemented
Trial: 17937798
Drug: Mental practice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mental practice embedded in daily therapy
Trial: 11427271
Drug: QS-21/4 mg/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QS-21/4 mg/ml of polysorbate 80
Trial: 11427271
Drug: QS-21/30 mg/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QS-21/30 mg/ml of hydroxypropyl-beta-cyclodextrin
Trial: 11427271
Drug: QS-21/8-mg/ml of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QS-21/8-mg/ml of polysorbate 80
Trial: 26016866
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (GFJ) 340 mL/d providing 210 mg naringenin glycosides
Trial: 23490394
Drug: Dynamic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic treatment (DT) for 24‐72 weeks based on viral decline rates
Trial: 23490394
Drug: Dynamic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic treatment (DT)
Trial: 23490394
Drug: Dynamic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic treatment (DT) among patients who achieved undetectable HCV RNA
Trial: 21733046
Drug: Incentive of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incentive of 1 month of free treatment every fourth month of regularly respected visits (Group 2)
Trial: 12924797
Drug: Vaccine group
RxNorm normalized name: MENINGOCOCCAL OLIGOSACCHARIDE VACCINE GROUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine group (received intramuscular injection with purified trivalent split‐virus vaccine)
Trial: 12924797
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (received intramuscular injection with vit B1)
Trial: 12924797
Drug: Vaccine group
RxNorm normalized name: MENINGOCOCCAL OLIGOSACCHARIDE VACCINE GROUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine group (mild COPD)
Trial: 12924797
Drug: Vaccine group
RxNorm normalized name: MENINGOCOCCAL OLIGOSACCHARIDE VACCINE GROUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine group (moderate COPD)
Trial: 12924797
Drug: Vaccine group
RxNorm normalized name: MENINGOCOCCAL OLIGOSACCHARIDE VACCINE GROUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine group (severe COPD)
Trial: 12924797
Drug: Vaccine group
RxNorm normalized name: MENINGOCOCCAL OLIGOSACCHARIDE VACCINE GROUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine group (all COPD patients)
Trial: 12924797
Drug: Vaccine group
RxNorm normalized name: MENINGOCOCCAL OLIGOSACCHARIDE VACCINE GROUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine group (patients with severe airflow obstruction)
Trial: 8634222
Drug: Chlorpromazine (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (administered over a 4-8 week period)
Trial: 1962780
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (cisplatin and vinblastine) followed by radiotherapy
Trial: 6115521
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg metoprolol (acute beta 1-adrenergic blockade)
Trial: 22796247
Drug: FF Rotadisk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF Rotadisk 100 μg once daily in the morning
Trial: 22796247
Drug: FF Rotadisk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF Rotadisk 100 μg once daily in the evening
Trial: 22796247
Drug: FF Rotadisk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF Rotadisk 250 μg once daily in the evening
Trial: 18558697
Drug: High Fructose
RxNorm normalized name: High Fructose Corn Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Fructose Corn Syrup (HFCS)
Trial: 16187917
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of octreotide-LAR every 4 weeks for 16 weeks
Trial: 7585851
Drug: Roxatidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxatidine (150 mg)
Trial: 7384769
Drug: Glucose syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose syrup ingestion in the morning
Trial: 28504033
Drug: Salvage chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvage chemotherapy (dexamethasone, cytarabine, cisplatin)
Trial: 25844857
Drug: Short-wave diathermy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-wave diathermy (SWD) heat treatment for 40 minutes
Trial: 10703777
Drug: IV tPA
RxNorm normalized name: tPA
DrugBank: Phorbol 12-myristate 13-acetate diester (DB17045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV tPA therapy
Trial: 8792483
Drug: 3-component DTaP
RxNorm normalized name: Perftoran component perfluorodecalin
DrugBank: Perfluorodecalin (DB16292)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-component DTaP vaccine
Trial: 8792483
Drug: 2-component DTaP
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-component DTaP vaccine
Trial: 6335343
Drug: Metoprolol group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol group (last metoprolol dose given 1.5 h before the anaesthesia)
Trial: 6335343
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (last metoprolol dose 12 h before the anaesthesia)
Trial: 26032211
Drug: 200 IU
RxNorm normalized name: Vitamin E 200 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 IU of intranasal salmon calcitonin daily for 3 months
Trial: 21804061
Drug: Lozenges containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lozenges containing anti-CA-gtf IgY
Trial: 16650295
Drug: Allopurinol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (100 mg tds for 3 months) with ofloxacin (200 mg tds for 3 weeks)
Trial: 16650295
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets with ofloxacin (200 mg tds for 3 weeks)
Trial: 14647985
Drug: Sole injection
RxNorm normalized name: English sole
DrugBank: English sole (DB10904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sole injection of NC into the lesion (group III)